Sutent News
Most Popular Sutent Story
Roche, Pfizer cancer meds fail trials
Talk about a double whammy: Two big cancer drugs failed late-stage trials that could have broadened their use considerably. Roche's Avastin didn't make the grade against prostate cancer, failing to... Read more...
Latest Headlines
- March 12, 2010
- March 8, 2010
- August 26, 2009
- July 1, 2009
- June 25, 2009
- June 2, 2009
- March 12, 2009
- February 4, 2009
- December 1, 2008
- August 7, 2008
- July 15, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
